APPLICATION
ANDA040036
TYPE
ANDA
ORIGINAL APPROVAL
1993-06-30
LATEST ACTION
2002-03-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
METHAZOLAMIDEPrescription
METHAZOLAMIDE 50MG · TABLET · ORAL
METHAZOLAMIDEPrescription
METHAZOLAMIDE 25MG · TABLET · ORAL
Approval history
2002-03-25Manufacturing (CMC) · Supplement 10AP
2001-08-13Manufacturing (CMC) · Supplement 9AP
2000-12-29Manufacturing (CMC) · Supplement 8AP
2000-12-27Manufacturing (CMC) · Supplement 7AP
2000-09-11Manufacturing (CMC) · Supplement 6AP
1999-05-05Manufacturing (CMC) · Supplement 5AP
1999-02-11Manufacturing (CMC) · Supplement 4AP
1998-09-25Manufacturing (CMC) · Supplement 3AP
1997-08-11Manufacturing (CMC) · Supplement 2AP
1996-04-10Manufacturing (CMC) · Supplement 1AP
1993-06-30OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.